Clinical Trial Update: Alpha1-antitrypsin Deficiency Registry

View source ↗

Summary

A completed NHLBI-sponsored clinical trial registry update for Alpha-1 antitrypsin deficiency and related lung diseases such as emphysema and COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Emphysema | Status: COMPLETED